Zhejiang Jiuzhou Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Yi Jiang Mei
Chief executive officer
CN¥3.6m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | 4.1yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Shares Leap 25% Yet They're Still Not Telling The Full Story
Oct 01
Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Seems To Use Debt Quite Sensibly
Sep 25Here's Why Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Can Manage Its Debt Responsibly
Jun 13Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Business And Shares Still Trailing The Market
May 24Zhejiang Jiuzhou Pharmaceutical's (SHSE:603456) Solid Earnings May Rest On Weak Foundations
May 01Zhejiang Jiuzhou Pharmaceutical Co., Ltd Just Missed Revenue By 17%: Here's What Analysts Think Will Happen Next
Apr 11Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) Shares Could Be 32% Above Their Intrinsic Value Estimate
Feb 28CEO
Yi Jiang Mei (49 yo)
6.3yrs
Tenure
CN¥3,615,000
Compensation
Mr. Yi Jiang Mei serves as Director at Zhejiang Jiuzhou Pharmaceutical Co., Ltd. since September 06, 2018, serves as its President and served as its Deputy General Manager.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | no data | CN¥3.62m | 0.11% CN¥ 14.4m | |
| Financial Manager | 3.6yrs | CN¥1.01m | 0.025% CN¥ 3.1m | |
| VP, Secretary of the Board of Directors & Director | no data | CN¥1.58m | 1.95% CN¥ 247.6m | |
| Vice President | no data | CN¥1.84m | 0.016% CN¥ 2.0m | |
| Vice President | 4.1yrs | CN¥1.35m | 0.011% CN¥ 1.3m | |
| Vice President | 4.1yrs | CN¥1.05m | 0.011% CN¥ 1.3m | |
| Vice President | no data | CN¥2.27m | 0.0013% CN¥ 170.0k |
4.1yrs
Average Tenure
48yo
Average Age
Experienced Management: 603456's management team is considered experienced (4.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | 6.3yrs | CN¥3.62m | 0.11% CN¥ 14.4m | |
| Financial Manager | 3.6yrs | CN¥1.01m | 0.025% CN¥ 3.1m | |
| VP, Secretary of the Board of Directors & Director | 10.1yrs | CN¥1.58m | 1.95% CN¥ 247.6m | |
| Chairman | 10.1yrs | CN¥2.51m | 3.56% CN¥ 452.1m | |
| Chairman of Supervisory Board | 10.1yrs | no data | no data | |
| Director | 10.1yrs | no data | no data | |
| Independent Director | 4.1yrs | CN¥160.00k | no data | |
| Independent Director | 4.1yrs | CN¥160.00k | no data | |
| Director | less than a year | CN¥13.30k | no data | |
| Independent Director | 1.3yrs | CN¥65.60k | no data |
5.2yrs
Average Tenure
52.5yo
Average Age
Experienced Board: 603456's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 22:20 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Jiuzhou Pharmaceutical Co., Ltd is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Xiyuan Liu | China International Capital Corporation Limited |
| Wanhua Wu | China International Capital Corporation Limited |